Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity

被引:50
作者
Navarrete-Vazquez, Gabriel [1 ]
Paoli, Paolo [2 ]
Leon-Rivera, Ismael [3 ]
Villalobos-Molina, Rafael [4 ]
Medina-Franco, Jose Luis [5 ]
Ortiz-Andrade, Rolffy [1 ,6 ]
Estrada-Soto, Samuel [1 ]
Camici, Guido [2 ]
Diaz-Coutino, Daniel [3 ]
Gallardo-Ortiz, Itzell [4 ]
Martinez-Mayorga, Karina [5 ]
Moreno-Diaz, Hermenegilda [1 ]
机构
[1] Univ Autonoma Estado Morelos, Fac Farm, Cuernavaca 62209, Morelos, Mexico
[2] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
[3] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca 62209, Morelos, Mexico
[4] Univ Nacl Autonoma Mexico, Unidad Biomed, FES Iztacala, Mexico City 54090, DF, Mexico
[5] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA
[6] Univ Autonoma Yucatan, Fac Quim, Merida 97150, Yucatan, Mexico
关键词
Benzothiazoles; Protein tyrosine phosphatase (PTP-1B); Diabetes; BIOLOGICAL-ACTIVITY SPECTRA; PREDICTION; RESISTANCE; OBESITY; PTP1B; ACIDS; SETS;
D O I
10.1016/j.bmc.2009.03.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 2-arylsulfonylaminobenzothiazole derivatives 1-27 were prepared using a one step reaction. The in vitro inhibitory activity of the compounds against protein tyrosine phosphatase 1B (PTP-1B) was evaluated. Compounds 4 and 16 are rapid reversible (mixed-type) inhibitors of PTP-1B with IC50 values in the low micromolar range. The most active compounds (4 and 16) were docked into the crystal structure of PTP-1B. Docking results indicate potential hydrogen bond interactions between the nitro group in both compounds and the catalytic amino acid residues Arg 221 and Ser 216. Both compounds were evaluated for their in vivo antihyperglycemic activity in a type 2 diabetes mellitus rat model, showing significant lowering of plasma glucose concentration, during the 7 h post-intragastric administration. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3332 / 3341
页数:10
相关论文
共 25 条
[1]  
[Anonymous], 2007, MOL OP ENV MOE
[2]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[3]   Inhibitors of protein tyrosine phosphatases: Next-generation drugs? [J].
Bialy, L ;
Waldmann, H .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (25) :3814-3839
[4]  
DeFronzo RA, 1997, DIABETES REV, V5, P177
[5]   Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [J].
Elchebly, M ;
Payette, P ;
Michaliszyn, E ;
Cromlish, W ;
Collins, S ;
Loy, AL ;
Normandin, D ;
Cheng, A ;
Himms-Hagen, J ;
Chan, CC ;
Ramachandran, C ;
Gresser, MJ ;
Tremblay, ML ;
Kennedy, BP .
SCIENCE, 1999, 283 (5407) :1544-1548
[6]   The Metabolic Syndrome - from Insulin Resistance to Obesity and Diabetes [J].
Gallagher, Emily Jane ;
LeRoith, Derek ;
Karnieli, Eddy .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (03) :559-+
[7]   ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY - A RAPID ACCESS TO ATOMIC CHARGES [J].
GASTEIGER, J ;
MARSILI, M .
TETRAHEDRON, 1980, 36 (22) :3219-3228
[8]   Prevention and treatment of type 2 diabetes: Current role of lifestyle, natural product, and pharmacological interventions [J].
Hays, Nicholas P. ;
Galassetti, Pietro R. ;
Coker, Robert H. .
PHARMACOLOGY & THERAPEUTICS, 2008, 118 (02) :181-191
[9]   VMD: Visual molecular dynamics [J].
Humphrey, W ;
Dalke, A ;
Schulten, K .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1996, 14 (01) :33-38
[10]   1,2,3,4-tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors [J].
Klopfenstein, SR ;
Evdokimov, AG ;
Colson, AO ;
Fairweather, NT ;
Neuman, JJ ;
Maier, MB ;
Gray, JL ;
Gerwe, GS ;
Stake, GE ;
Howard, BW ;
Farmer, JA ;
Pokross, ME ;
Downs, TR ;
Kasibhatla, B ;
Peters, KG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) :1574-1578